BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19673746)

  • 1. A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence.
    Brown ES; Carmody TJ; Schmitz JM; Caetano R; Adinoff B; Swann AC; John Rush A
    Alcohol Clin Exp Res; 2009 Nov; 33(11):1863-9. PubMed ID: 19673746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence.
    Farren CK; Scimeca M; Wu R; Malley SO
    Drug Alcohol Depend; 2009 Jan; 99(1-3):317-21. PubMed ID: 18644685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial.
    Morley KC; Kranzler HR; Luquin N; Jamshidi N; Adams C; Montebello M; Tremonti C; Dali G; Logge W; Baillie A; Teesson M; Trent R; Haber PS
    Am J Psychiatry; 2024 May; 181(5):403-411. PubMed ID: 38706338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Naltrexone for the Treatment of Alcohol Dependence in Latino Populations.
    López CM; Barr SC; Reid-Quiñones K; de Arellano MA
    J Stud Alcohol Drugs; 2017 May; 78(4):629-634. PubMed ID: 28728646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose naltrexone therapy for cocaine-alcohol dependence.
    Schmitz JM; Lindsay JA; Green CE; Herin DV; Stotts AL; Moeller FG
    Am J Addict; 2009; 18(5):356-62. PubMed ID: 19874153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial.
    O'Malley SS; Robin RW; Levenson AL; GreyWolf I; Chance LE; Hodgkinson CA; Romano D; Robinson J; Meandzija B; Stillner V; Wu R; Goldman D
    Alcohol Clin Exp Res; 2008 Jul; 32(7):1271-83. PubMed ID: 18482155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.
    Pettinati HM; Kampman KM; Lynch KG; Suh JJ; Dackis CA; Oslin DW; O'Brien CP
    J Subst Abuse Treat; 2008 Jun; 34(4):378-90. PubMed ID: 17664051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of late-life depression complicated by alcohol dependence.
    Oslin DW
    Am J Geriatr Psychiatry; 2005 Jun; 13(6):491-500. PubMed ID: 15956269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence.
    Petrakis IL; Ralevski E; Desai N; Trevisan L; Gueorguieva R; Rounsaville B; Krystal JH
    Neuropsychopharmacology; 2012 Mar; 37(4):996-1004. PubMed ID: 22089316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative symptoms are associated with less alcohol use, craving, and "high" in alcohol dependent patients with schizophrenia.
    Batki SL; Leontieva L; Dimmock JA; Ploutz-Snyder R
    Schizophr Res; 2008 Oct; 105(1-3):201-7. PubMed ID: 18701256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the efficacy of naltrexone based on trajectory-based reanalyses of two negative clinical trials.
    Gueorguieva R; Wu R; Pittman B; Cramer J; Rosenheck RA; O'malley SS; Krystal JH
    Biol Psychiatry; 2007 Jun; 61(11):1290-5. PubMed ID: 17224132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of alcohol and hepatitis C: a secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependence.
    Plebani JG; Tirado CF; Pettinati HM; Kampman KM; Volpicelli JR; Oslin DW
    Addict Behav; 2010 Feb; 35(2):123-8. PubMed ID: 19783106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence.
    Garbutt JC; Osborne M; Gallop R; Barkenbus J; Grace K; Cody M; Flannery B; Kampov-Polevoy AB
    Alcohol Alcohol; 2009; 44(3):293-300. PubMed ID: 19189996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attributions of change and self-efficacy in a randomized controlled trial of medication and psychotherapy for problem drinking.
    Schaumberg K; Kuerbis A; Morgenstern J; Muench F
    Behav Ther; 2013 Mar; 44(1):88-99. PubMed ID: 23312429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses.
    Lim AC; Grodin EN; Green R; Venegas A; Meredith LR; Courtney KE; Moallem NR; Sayegh P; London ED; Ray LA
    Am J Drug Alcohol Abuse; 2020 Sep; 46(5):565-576. PubMed ID: 32343625
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients: Design and Implementation.
    Greenfield SF; Shields A; Connery HS; Livchits V; Yanov SA; Lastimoso CS; Strelis AK; Mishustin SP; Fitzmaurice G; Mathew TA; Shin S
    Alcohol Clin Exp Res; 2010 Feb; 34(2):317-30. PubMed ID: 19930235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported Past Experiences With Naltrexone and Attitudes Toward Daily Adherence Among High-utilization Patients With Alcohol Use Disorder.
    Terasaki D
    J Addict Med; 2023 May-Jun 01; 17(3):371-372. PubMed ID: 37267196
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and tolerability of topiramate and N-acetyl cysteine combination in individuals with alcohol use disorder: a 12 week, randomized, double-blind, pilot study.
    Tiouririne NA; Kalelioglu T; Seneviratne C; Wang XQ
    Alcohol Alcohol; 2024 Jan; 59(2):. PubMed ID: 38069498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitatively and quantitatively evaluating harm-reduction goal setting among chronically homeless individuals with alcohol dependence.
    Collins SE; Grazioli VS; Torres NI; Taylor EM; Jones CB; Hoffman GE; Haelsig L; Zhu MD; Hatsukami AS; Koker MJ; Herndon P; Greenleaf SM; Dean PE
    Addict Behav; 2015 Jun; 45():184-90. PubMed ID: 25697724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot RCT comparing low-dose naltrexone, gabapentin and placebo to reduce pain among people with HIV with alcohol problems.
    Tsui JI; Rossi SL; Cheng DM; Bendiks S; Vetrova M; Blokhina E; Winter M; Gnatienko N; Backonja M; Bryant K; Krupitsky E; Samet JH
    PLoS One; 2024; 19(2):e0297948. PubMed ID: 38408060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.